5 best ETFs to buy in 2020

  • By James Royal,
  • Bankrate.com
  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print

Exchange-traded funds (ETFs) have become tremendously popular because they allow investors to quickly own a diversified set of securities, such as stocks, at a low cost. They also allow investors to get very specific exposure to areas of the market, such as countries, industries and asset classes.

ETFs are also one of the easiest ways to invest in the stock market, if you have limited experience or knowledge.

How ETFs work

ETFs are funds that hold a group of assets such as stocks, bonds or others. Their shares trade on an exchange like a stock, and they allow investors to acquire an interest in all the fund’s holdings by buying just one share. The minimum cost to get into the market is just the cost of one share, often in the range of $20 – $200. So it doesn’t require a massive investment to start.

Since many ETFs hold such a broad array of stocks, they’re often considered diversified, helping protect investors from a drop in any single stock. That’s especially true for broadly diversified ETFs – such as those based on the Standard & Poor’s 500 index (.SPX) – because they hold shares across every industry. But it’s less true for more narrowly focused funds, such as those based on a single industry or country. This diversification is a key advantage of ETFs over individual stocks.

While they trade on a stock exchange, ETFs can give you exposure to almost any kind of asset. Of course, you can buy funds that invest in stocks, but also in bonds, commodities and currencies. You can even find a fund that invests in the volatility of the major indexes.

There’s also another type of ETF called a leveraged ETF, which is designed to provide double or triple the exposure to the underlying investment. They aim to track the daily performance of their stocks, so if the stocks go up 1 percent, these ETFs are supposed to go up 2 percent or 3 percent, depending on the type of fund. But they also go down a similar amount, too, if the stocks move that way. In addition, leveraged ETFs have other risks that investors should pay attention to, and these are not the best securities for beginning investors.

Is an ETF a good type of investment?

ETFs tend to have very low expense ratios – the cheapest funds cost just a few dollars for each $10,000 invested. In large part, that’s because they’re passive investments, meaning that they use preset indexes to determine what they own, rather than paying high-priced investment managers to actively scour the market for the best holdings. The goal of a passive ETF is to track the performance of the index that it follows, not beat it.

Another huge boon for investors is that most major online brokers have made ETFs commission-free. That means you can get into and out of the market without paying trading fees, another benefit over individual stocks, making ETFs even better for cost-conscious investors.

5 top ETFs for 2020

Here are five top ETFs for 2020 that investors may want to consider, based on their recent performance, their expense ratio, and the kind of exposure that they offer investors.

Top tech ETF – Invesco QQQ Trust

2019 performance: +38.6 percent

Net assets: $87 billion

Expense ratio: 0.20 percent

The Invesco QQQ Trust (QQQ) owns only non-financial Nasdaq stocks, making it a tech-heavy fund with the big names that you’re probably already familiar with. The ETF is one of the largest around, so it’s tremendously liquid. It’s not too expensive either, with the fund costing $20 annually for every $10,000 invested. The solid performance in 2019 reflected the broader market of tech names that soared.

Top S&P 500 ETF – Vanguard S&P 500 ETF

2019 performance: +31 percent

Net assets: $520 billion

Expense ratio: 0.03 percent

The Vanguard S&P 500 ETF (VOO) tracks the S&P 500, providing a broad-based, diversified portfolio of the largest American companies. The fund is sponsored by one of the leaders in low-cost ETF investing, Vanguard, and the fund itself has a massive $520 billion in assets. The fund was opened in 2010, and has a razor-thin annual cost of just $3 for every $10,000 invested. The solid performance in 2019 reflects the market’s overall gain of 28.9 percent.

Top VIX ETF – ProShares VIX Short-Term Futures ETF

2019 performance: -67.8 percent

Net assets: $295 million

Expense ratio: 0.85 percent

This ETF (VIXY) is unusual in the fund world, because it allows investors to profit on the volatility of the market, rather than a specific security. If volatility moves higher, this ETF increases in value, generally moving inversely to the direction of the stock market. It’s better as a short-term trade than a long-term investment, however, because it has to roll derivatives contracts regularly, costing the fund money over time. Despite relatively few assets, the fund is liquid, and its expense ratio is in line with others in this niche space – costing $85 annually for each $10,000 invested. The strong performance of the stock market in 2019 led to a poor performance for this ETF.

Top high-dividend ETF – Vanguard High Dividend Yield

2019 performance: +23 percent

Net assets: $38 billion

Expense ratio: 0.06 percent

This Vanguard ETF (VYM) tracks the FTSE High Dividend Yield Index, which includes American stocks paying high-dividend yields. The fund has $38 billion under management, making it highly liquid, and it’s sponsored by one of the most reputable names in the business, Vanguard. The fund was founded in 2006 and charges just $6 for every $10,000 invested, so it doesn’t cut into the meaty dividend payout too much. The fund’s strong performance in 2019 reflects the broader market’s rise.

Top biotech ETF – SPDR S&P Biotech ETF

2019 performance: +32.6 percent

Net assets: $4.3 billion

Expense ratio: 0.35 percent

Biotech is one of the hottest sectors in the market, and the SPDR S&P Biotech ETF (XBI) allows you to own a selection of some of its hottest companies. At a cost of $35 for every $10,000 invested, the fund charges more than many funds on our list, but it sits near the bottom of ETFs covering this sector. And the fund’s diversification is necessary if you’re not an expert in the many different scientific approaches at the various companies. However, if investors’ sentiment changes, the risky biotech may be one of the first to be affected. The fund has more than $4 billion under management, and was founded in 2006.

Bottom line

ETFs can be one of the easier and safer ways for investors to get into the stock market, because they offer immediate diversification, regardless of how much you invest. To get started, you’ll want to open a brokerage account, one that’s especially focused on the needs of ETF investors.

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print

For more news you can use to help guide your financial life, visit our Insights page.


© Copyright 2020 Bankrate, Inc. All rights reserved.
Votes are submitted voluntarily by individuals and reflect their own opinion of the article's helpfulness. A percentage value for helpfulness will display once a sufficient number of votes have been submitted.
close
Please enter a valid e-mail address
Please enter a valid e-mail address
Important legal information about the e-mail you will be sending. By using this service, you agree to input your real e-mail address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an e-mail. All information you provide will be used by Fidelity solely for the purpose of sending the e-mail on your behalf.The subject line of the e-mail you send will be "Fidelity.com: "

Your e-mail has been sent.
close

Your e-mail has been sent.